Oragenics, Inc. announced on January 21, 2025, the appointment of Janet Huffman as its new interim Chief Executive Officer. Ms. Huffman has played a pivotal role in driving the company’s strategy since joining Oragenics.
Her extensive experience includes capital raising, mergers and acquisitions, and financial planning. Prior to Oragenics, she served as CFO for TRxADE HEALTH, Inc. and was a founding member and CFO of Banyan Pediatric Care Centers.
The Board of Directors expressed confidence in Ms. Huffman’s leadership, citing her proven track record and deep understanding of Oragenics’ operations. She is expected to guide the company during this pivotal time as it advances ONP-002.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.